Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme
PMID: 38869019
Source: J Crohns Colitis
Publication date:
2025-07-24
Year:
2024
Abstract
NULL